Product Management
  • Product Management
  • All

UTP, Tris Buffered


This product can serve as a substrate for cell-free protein expression systems and is also suitable for use in in vitro transcription reactions with SP6, T3, and T7 RNA polymerases to generate RNA probes, or for RNA transcription followed by translation in an in vitro translation extract.

GTP, Tris Buffered


This product can serve as a substrate for cell-free protein expression systems and is also suitable for use in in vitro transcription reactions with SP6, T3, and T7 RNA polymerases to generate RNA probes, or for RNA transcription followed by translation in an in vitro translation extract.

CTP, Tris Buffered


This product can serve as a substrate for cell-free protein expression systems and is also suitable for use in in vitro transcription reactions with SP6, T3, and T7 RNA polymerases to generate RNA probes, or for RNA transcription followed by translation in an in vitro translation extract.

ATP, Tris Buffered


This product can serve as a substrate for cell-free protein expression systems and is also suitable for use in in vitro transcription reactions conducted with SP6, T3, and T7 RNA polymerases to generate RNA probes, or for RNA transcription followed by translation in an in vitro translation extract. Additionally, ATP can act as a cofactor for T4 DNA ligase, catalyzing its ligation reaction.

CAP GAG (3'OMe)


The CAP GAG (3'OMe) cap analog has the structure m7(3'OMeG)(5')ppp(5')(2'OMeA)pG. Compared to CAP GAG, this cap analog exhibits anti-reverse-transcription activity and demonstrates superior biological performance in certain DNA templates or specific sequences.

CAP GAG


CAP GAG is a single-component cap analog with the structure m7G(5')ppp(5')(2'OMeA)pG. This product is designed for use with DNA templates whose starting sequence is 5'-AG… and enables the one-step co-transcriptional capping process to generate the native Cap1 structure.

N1-methyl-Pseudo-UTP 100 mM solution


This product is a modified nucleotide that can replace natural UTP and be incorporated into mRNA via in vitro transcription, thereby reducing the mRNA’s intrinsic immunogenicity. At the same time, by increasing ribosome-binding efficiency, it can further enhance the expression efficiency of the mRNA.
< 12 >